The U.S. immunoassay market, valued at USD 11.72 billion in 2024, is expected to expand at a CAGR of 4.6% from 2025 to 2034, driven by evolving clinical and research applications across segmented product lines and end-user industries. This growth is not uniform but is instead shaped by distinct segment dynamics, including product type, application area, and end-user demand. As the market...
Greek 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)